Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Non-Pharmaceutical Interventions for Pandemic Influenza, Request for Applications (RFA) CI06-010, 44031 [E6-12542]

Download as PDF Federal Register / Vol. 71, No. 149 / Thursday, August 3, 2006 / Notices FOR FURTHER INFORMATION CONTACT: DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the National Coordinator for Health Information Technology; American Health Information Community Electronic Health Record Workgroup Meeting ACTION: Announcement of meeting. This notice announces the eighth meeting of the American Health Information Community Electronic Health Record Workgroup in accordance with the Federal Advisory Committee Act (Pub. L. 92–463, 5 U.S.C., App.) SUMMARY: DATES: http://www.hhs.gov/healthit/ahic/ bio_main.html. The meeting will be available via Web cast at http://www.eventcenterlive.com/ cfmx/ec/login/login1.cfm?BID=67. SUPPLEMENTARY INFORMATION: Dated: July 25, 2006. Judith Sparrow, Director, American Health Information Community, Office of Programs and Coordination, Office of the National Coordinator for Health Information Technology. [FR Doc. 06–6661 Filed 8–2–06; 8:45am] BILLING CODE 4150–24–M August 15, 2006 from 1 p.m. to 5 p.m. Mary C. Switzer Building (330 C Street, SW., Washington, DC 20201), Conference Room 4090 (please bring photo ID for entry to a Federal building). DEPARTMENT OF HEALTH AND HUMAN SERVICES http:// www.hhs.gov/healthit/ahic/ bio_main.html. Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Non-Pharmaceutical Interventions for Pandemic Influenza, Request for Applications (RFA) CI06– 010 ADDRESSES: FOR FURTHER INFORMATION: The meeting will be available via Web cast at http://www.eventcenterlive.com/ cfmx/ec/login/login1.cfm.?BID=67. SUPPLEMENTARY INFORMATION: Dated: July 25, 2006. Judith Sparrow, Director, American Health Information Community, Office of Programs and Coordination, Office of the National Coordinator for Health Information Technology. [FR Doc. 06–6662 Filed 8–2–06; 8:45 am] BILLING CODE 4150–24–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the National Coordinator for Health Information Technology; American Health Information Community Chronic Care Workgroup Meeting ACTION: Announcement of meeting. SUMMARY: This notice announces the eighth meeting of the American Health Information Community Chronic Care Workgroup in accordance with the Federal Advisory Committee Act (Pub. L. 92–463, 5 U.S., App.). hsrobinson on PROD1PC69 with NOTICES DATES: August 16, 2006 from 1 p.m. to 5 p.m. Mary C. Switzer Building (330 C Street, SW., Washington, DC 20201), Conference Room 4090 (please bring photo ID for entry to a Federal building). ADDRESSES: VerDate Aug<31>2005 15:20 Aug 02, 2006 Jkt 208001 Centers for Disease Control and Prevention (CDC) Correction: This notice was published in the Federal Register on July 13, 2006, Volume 71, Number 134, page 39683. The date has been changed due to reviewer’s conflict with the original date. The meeting will be held on August 28, 2006. Title: Non-Pharmaceutical Interventions for Pandemic Influenza, RFA CI06–010. Contact Person for more Information: Felix Rogers, Ph.D., Scientific Review Administrator, National Immunization Program, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS E–05, Atlanta, GA 30333, Telephone 404.639.6101. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: July 27, 2006. Alvin Hall, Director, Management Analysis and Services Office Centers for Disease Control and Prevention. [FR Doc. E6–12542 Filed 8–2–06; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00019 Fmt 4703 Sfmt 4703 44031 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. 2006E–0189] Determination of Regulatory Review Period for Purposes of Patent Extension; IPLEX AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) has determined the regulatory review period for IPLEX and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Director of Patents and Trademarks, Department of Commerce, for the extension of a patent which claims that human drug product. ADDRESSES: Submit written comments and petitions to the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Submit electronic comments to http:// www.fda.gov/dockets/ecomments. FOR FURTHER INFORMATION CONTACT: Beverly Friedman, Office of Regulatory Policy (HFD–7), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301–594–2041. SUPPLEMENTARY INFORMATION: The Drug Price Competition and Patent Term Restoration Act of 1984 (Public Law 98– 417) and the Generic Animal Drug and Patent Term Restoration Act (Public Law 100–670) generally provide that a patent may be extended for a period of up to 5 years so long as the patented item (human drug product, animal drug product, medical device, food additive, or color additive) was subject to regulatory review by FDA before the item was marketed. Under these acts, a product’s regulatory review period forms the basis for determining the amount of extension an applicant may receive. A regulatory review period consists of two periods of time: A testing phase and an approval phase. For human drug products, the testing phase begins when the exemption to permit the clinical investigations of the human drug product becomes effective and runs until the approval phase begins. The approval phase starts with the initial submission of an application to market the human drug product and continues until FDA grants permission to market the drug product. Although only a portion of a regulatory review period E:\FR\FM\03AUN1.SGM 03AUN1

Agencies

[Federal Register Volume 71, Number 149 (Thursday, August 3, 2006)]
[Notices]
[Page 44031]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-12542]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention (CDC)


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel: Non-Pharmaceutical Interventions for Pandemic 
Influenza, Request for Applications (RFA) CI06-010

    Correction: This notice was published in the Federal Register on 
July 13, 2006, Volume 71, Number 134, page 39683. The date has been 
changed due to reviewer's conflict with the original date. The meeting 
will be held on August 28, 2006.
    Title: Non-Pharmaceutical Interventions for Pandemic Influenza, RFA 
CI06-010.
    Contact Person for more Information: Felix Rogers, Ph.D., 
Scientific Review Administrator, National Immunization Program, Centers 
for Disease Control and Prevention, 1600 Clifton Road NE., MS E-05, 
Atlanta, GA 30333, Telephone 404.639.6101.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both CDC and the Agency for Toxic Substances and Disease Registry.

    Dated: July 27, 2006.
Alvin Hall,
Director, Management Analysis and Services Office Centers for Disease 
Control and Prevention.
 [FR Doc. E6-12542 Filed 8-2-06; 8:45 am]
BILLING CODE 4163-18-P